Comprehensive product protection

We understand the importance of protecting our development products and IBsolvMIR is covered by a composition of matter and multiple specific-use patents. Its orphan drug designations ensure protocol assistance from the EMA and FDA during development, lower regulatory fees, and extended protection against direct competition.